sphingosine kinase inhibitor (University of Virgina)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namesphingosine kinase inhibitor (University of Virgina)
Drug Alias NameVPC-94075
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine kinase inhibitors
TargetsSphingosine kinase
Therapy Area/IndicationsVascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Virginia
Active IndicationsN/A
Inactive IndicationsVascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A